Entyvio (vedolizumab) long-term study: An international observational prospective cohort study comparing vedolizumab to other biologic agents in patients with ulcerative colitis or Crohn's Disease. [Entyvio PASS Study]
The purpose of this study is to obtain long-term safety information on the disease and medications that you received or are receiving for your Inflammatory Bowel Disease. Crohn’s Disease is characterized by inflammation (the ch ...